Prilocaine
Prilocaine is an amide-type local anesthetic that reversibly blocks voltage-gated sodium channels in nerve membranes, preventing sodium ion influx and thereby inhibiting generation and conduction of action potentials. It is used for infiltration anesthesia, nerve blocks, epidural anesthesia, and in combination with lidocaine as a topical eutectic mixture (EMLA) for skin analgesia.
น้ำหนักโมเลกุล
220.3100 g/mol
LogP
2.10
TPSA
41.10 Ų
Lipinski RO5
ผ่าน
ด้านการรักษา
กลไกการออกฤทธิ์
Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.
โครงสร้าง 2 มิติ
Cite this structure
Embed this structure
SMILES
CCCNC(C)C(=O)Nc1ccccc1C
InChI
InChI=1S/C13H20N2O/c1-4-9-14-11(3)13(16)15-12-8-6-5-7-10(12)2/h5-8,11,14H,4,9H2,1-3H3,(H,15,16)
Molecular Formula
C13H20N2O
HBD / HBA
2 / 2
พันธะที่หมุนได้
5
อะตอมหนัก
16
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
คำถามที่พบบ่อย
Prilocaine is an amide-type local anesthetic that reversibly blocks voltage-gated sodium channels in nerve membranes, preventing sodium ion influx and thereby inhibiting generation and conduction of action potentials. It is used for infiltration anesthesia, nerve blocks, epidural anesthesia, and in combination with lidocaine as a topical eutectic mixture (EMLA) for skin analgesia.
Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.
Yes, Prilocaine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1194. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 4906. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.
ข้อจำกัดความรับผิดชอบทางการแพทย์
This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="prilocaine"></div>
Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/prilocaine/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>
Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/prilocaine/
Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/prilocaine/)
Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="prilocaine"></drugfyi-drug>